The increasing prevalence of respiratory diseases, such as asthma, COPD, and cystic fibrosis, is driving the growth of the respiratory inhalers market. According to the World Health Organization (WHO), asthma affects 235 million people worldwide, while COPD affects 251 million people. The rising geriatric population, growing pollution levels, and lifestyle changes are further contributing to...
0 Commentarios
0 Acciones
1297 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian